Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy

AIDS

Volumn 17, Issue 16, 2003, Pages 2323-2330

  Fondere, Jean Michel ^a   Huguet, Marie France ^a   Yssel, Hans ^b   Baillat, Vincent ^a,c   Reynes, Jacques ^c   Van De Perre, Philippe ^a   Vendrell, Jean Pierre ^a,b  

^a LAPEYRONIE HOSPITAL   (France)

^b INSERM   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Combined antiretroviral therapy; HIV 1 specific memory B cells

Indexed keywords

ANTIRETROVIRUS AGENT; CD40 ANTIGEN; CD40 LIGAND; CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; PROTEINASE INHIBITOR; PROTOZOON ANTIBODY; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GENETIC TRANSFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE CULTURE; MEMORY CELL; PERIPHERAL LYMPHOCYTE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIBODY SPECIFICITY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; B-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; CHRONIC DISEASE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; VIRAL LOAD; VIRUS REPLICATION;

EID: 0742287274     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200311070-00006     Document Type: Article

References (64)

1. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 1988, 82:1908-1914.
2. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983, 309:453-458.
3. Schnittman SM, Lane HC, Higgins SE, Folks T, Fauci AS. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986, 233: 1084-1086.
4. Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 1987, 138:3720-3724.
5. Amadori A, De Rossi A, Faulkner-Valle GP, Chieco-Bianchi L. Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin Immunol Immunopathol 1988, 46:342-351.
6. Vendrell JP, Segondy M, Ducos J, Reynes J, Huguet MF, Nicolas JC, et al. Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection. Clin Exp Immunol 1991, 83:197-202.
7. Rosenberg YJ, Lewis MG, Kosco-Vilbois MH. Enhanced follicular dendritic cell-B cell interaction in HIV and SIV infections and its potential role in polyclonal B cell activation. Dev Immunol 1998, 6:61-70.
8. de Wolf F, Goudsmit J, Paul DA, Lange JM, Hooijkaas C, Schellekens P, et al. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J 1987, 295:569-572.
9. Fenouillet E, Blanes N, Coutellier A, Demarquest J, Rozenbaum W, Gluckman JC. Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic marker. J Infect Dis 1992, 166:611-616.
10. Strathdee SA, Frank JW, McLaughlin J, Leblanc M, Major C, O'Shaughnessy MV, et al. Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS. J Infect Dis 1995, 172:1375-1379.
11. Berberian L, Goodglick L, Kipps TJ, Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 1993, 261:1588-1591.
12. Widney D, Gundapp G, Said JW, van der Meijden M, Bonavida B, Demidem A, et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol 1999, 93:114-123.
13. De Milito A, Morch C, Sonnerborg A, Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 2001, 15: 957-964.
14. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 1984, 251:1447-1449.
15. Ballet JJ, Sulcebe G, Couderc LJ, Danon F, Rabian C, Lathrop M, et al. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol 1987, 68:479-487.
16. Pahwa S, Pahwa R, Good RA, Gallo RC, Saxinger C. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. Proc Natl Acad Sci USA 1986, 83: 9124-9128.
17. Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 1992, 89: 561-566.
18. Rautonen J, Rautonen N, Martin NL, Wara DW. HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1994, 10:781-785.
19. Chirmule N, Oyaizu N, Saxinger C, Pahwa S. Nef protein of HIV-1 has B-cell stimulatory activity. AIDS 1994, 8:733-734.
20. Chirmule N, McCloskey TW, Hu R, Kalyanaraman VS, Pahwa S. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol 1995, 155:917-924.
21. Hagiwara E, Sacks T, Leitman-Klinman SF, Klinman DM. Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood. AIDS Res Hum Retroviruses 1996, 12:127-133.
22. Morris L, Binley JM, Clas BA, Bonhoeffer S, Astill TP, Kost R, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998, 188:233-245.
23. Fournier AM, Baillat V, Alix-Panabieres C, Fondere JM, Merle C, Segondy M, et al. Dynamics of spontaneous HIV-1-specific and -nonspecific B-cell responses in patients receiving antiretroviral therapy. AIDS 2002, 16:1755-1760.
24. MacLennan IC, Liu YJ, Johnson GD. Maturation and dispersal of B-cell clones during T cell-dependent antibody responses. Immunol Rev 1992, 126:143-161.
25. MacLennan IC. Germinal centers. Annu Rev Immunol 1994, 12:117-139.
26. Liu YJ, Arpin C. Germinal center development. Immunol Rev 1997, 156:111-126.
27. Banchereau J, Rousset F. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol 1992, 52: 125-262.
28. MacLennan IC, Gulbranson-Judge A, Toellner KM, Casamayor-Palleja M, Chan E, Sze DM, et al. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev 1997, 156:53-66.
29. Rajewsky K. Burnet's unhappy hybrid. Nature 1998, 394: 624-625.
30. Agematsu K, Nagumo H, Yang FC, Nakazawa T, Fukushima K, Ito S, et al. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 1997, 27:2073-2079.
31. Klein U, Küppers R, Rajewsky K. Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol 1993, 23:3272-3277.
32. Klein U, Küppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 1997, 89:1288-1298.
33. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998, 188:1679-1689.
34. Karrer U, Lopez-Macias C, Oxenius A, Odermatt B, Bachmann MF, Kalinke U, et al. Antiviral B cell memory in the absence of mature follicular dendritic cell networks and classical germinal centers in TNFR1-/-mice. J Immunol 2000, 164:768-778.
35. Coffman RL, Cohn M. The class of surface immunoglobulin on virgin and memory B lymphocytes. J Immunol 1977, 118: 1806-1815.
36. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992, 175: 671-682.
37. Zubler RH, Perrin LH, Doucet A, Zhang X, Huang YP, Miescher PA. Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Clin Exp Immunol 1992, 87:31-36.
38. Conge AM, Reynes J, Atoui N, Huguet MF, Ducos J, Bonardet A, et al. Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults. J Infect Dis 1994, 170:1376-1383.
39. Cordoba F, Lavabre-Bertrand T, Salhi SL, Huguet MF, Gerfaux J, Rossi JF, et al. Spontaneous monoclonal immunoglobulin-secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma. Br J Haematol 2000, 108: 549-558.
40. Lacascade C, Conge AM, Baillat V, Pages I, Huguet MF, Reynes J, et al. In vitro anti-Toxoplasma gondii antibody production by peripheral blood mononuclear cells in the diagnosis and the monitoring of toxoplasmic encephalitis in AIDS-related brain lesions. J Acquir Immune Defic Syndr 2000, 25:256-260.
41. Kindler V, Zubler RH. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J Immunol 1997, 159:2085-2090.
42. Conge A-M, Tarte K, Reynes J, Segondy M, Gerfaux J, Zembala M, et al. Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1 disease. AIDS 1998, 12:1437-1449.
43. Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD, et al. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol 1997, 71:2799-2809.
44. Lee FK, Nahmias AJ, Lowery S, Nesheim S, Reef S, Thompson S, et al. ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection. AIDS Res Hum Retroviruses 1989, 5:517-523.
45. Amadori A, Zamarchi R, Ciminale V, Merle C, Baillat V, Huguet MF, et al. HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol 1989, 143:2146-2152.
46. Fournier AM, Fondere JM, Alix-Panabieres C, Del Mistro A, Siervo S, Alberti A, et al. Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells. Clin Immunol 2002, 103:98-109.
47. Bachmann MF, Kundig TM, Odermatt B, Hengartner H, Zinkernagel RM. Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. J Immunol 1994, 153:3386-3397.
48. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987, 40:153-245.
49. Pollack H, Zhan MX, Moore T, Tao PZ, Krasinski K, Borkowsky W. Effects of antiviral therapy on the production of anti-human immunodeficiency virus-specific immunoglobulin in infants and children. J Infect Dis 1994, 170:1003-1006.
50. Berberian L, Shukla J, Jefferis R, Braun J. Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo. J Acquir Immune Defic Syndr 1994, 7:641-646.
51. Karray S, Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc Natl Acad Sci USA 1997, 94:1356-1360.
52. Eris JM, Basten A, Brink R, Doherty K, Kehry MR, Hodgkin PD. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci USA 1994, 91:4392-4396.
53. Gray D, Skarvall H. B-cell memory is short-lived in the absence of antigen. Nature 1988, 336:70-73.
54. Tew JC, Mandel TE. Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice. Immunology 1979, 37:69-76.
55. Vieira P, Rajewsky K. Persistence of memory B cells in mice deprived of T cell help. Int Immunol 1990, 2:487-494.
56. Maruyama M, Lam KP, Rajewsky K. Memory B-cell persistence is independent of persisting immunizing antigen. Nature 2000, 407:636-642.
57. Hlavacek WS, Wofsy C, Perelson AS. Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis. Proc Natl Acad Sci USA 1999, 96:14681-14686.
58. Orenstein JM, Feinberg M, Yoder C, Schrager L, Mican JM, Schwartzentruber DJ, et al. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient. AIDS 1999, 13:2219-2229.
59. Tenner-Racz K, Stellbrink HJ, van Lunzen J, Schneider C, Jacobs JP, Raschdorff B, et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998, 187:949-959.
60. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection [see comments]. Nature 1997, 387:183-188.
61. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
62. Nunnari C, Otero M, Dornadula G, Vanella M, Zhang H, Frank I, et al. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS 2002, 16:39-45.
63. Chun TW, Justement JS, Pandya P, Hallahan CW, McLaughlin M, Liu S, et al. Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+-CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis 2002, 185:1672-1676.
64. Notermans DW, de Jong JJ, Goudsmit J, Bakker M, Roos MT, Nijholt L, et al. Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Res Hum Retroviruses 2001, 17:1003-1008.